 | • レポートコード：QYR9ST04898 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、免疫介在性炎症性疾患治療の世界市場について調査・分析し、免疫介在性炎症性疾患治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（標的生物療法、新規療法）、用途別（病院、薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫介在性炎症性疾患治療市場動向 ・主要企業別マーケットシェア ・免疫介在性炎症性疾患治療の種類別市場規模2014-2019 （標的生物療法、新規療法） ・免疫介在性炎症性疾患治療の用途別市場規模2014-2019 （病院、薬局、オンライン薬局） ・免疫介在性炎症性疾患治療の北米市場：主要企業・種類別/用途別市場規模 ・免疫介在性炎症性疾患治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・免疫介在性炎症性疾患治療の中国市場：主要企業・種類別/用途別市場規模 ・免疫介在性炎症性疾患治療の日本国内市場：主要企業・種類別/用途別市場規模 ・免疫介在性炎症性疾患治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・免疫介在性炎症性疾患治療のインド市場：主要企業・種類別/用途別市場規模 ・免疫介在性炎症性疾患治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Eli Lilly、AstraZeneca、Bristol-Myers、Sanofi、Roche、Enlivex Therapeutics、Immune Pharmaceuticals、Tanabe Pharma） ・免疫介在性炎症性疾患治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.In 2018, the global Immune-Mediated Inflammatory Diseases Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immune-Mediated Inflammatory Diseases Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune-Mediated Inflammatory Diseases Treatment development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Market segment by Type, the product can be split into
Targeted biologic therapies
Novel therapies
Market segment by Application, split into
Hospitals
Pharmacy Store
Online Pharmacy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immune-Mediated Inflammatory Diseases Treatment status, future forecast, growth opportunity, key market and key players.
To present the Immune-Mediated Inflammatory Diseases Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immune-Mediated Inflammatory Diseases Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Targeted biologic therapies
1.4.3 Novel therapies
1.5 Market by Application
1.5.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmacy Store
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size
2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions
2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2014-2025)
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Manufacturers
3.1.1 Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
3.3 Key Players Immune-Mediated Inflammatory Diseases Treatment Product/Solution/Service
3.4 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
5.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in United States
5.3 United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
5.4 United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
6 Europe
6.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
6.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Europe
6.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
6.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
7 China
7.1 China Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
7.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in China
7.3 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
7.4 China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
8 Japan
8.1 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
8.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Japan
8.3 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
8.4 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
9.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Southeast Asia
9.3 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
9.4 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
10 India
10.1 India Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
10.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in India
10.3 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
10.4 India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size (2014-2019)
11.2 Immune-Mediated Inflammatory Diseases Treatment Key Players in Central & South America
11.3 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
11.4 Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Bristol-Myers
12.4.1 Bristol-Myers Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.4.5 Bristol-Myers Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Enlivex Therapeutics
12.7.1 Enlivex Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.7.5 Enlivex Therapeutics Recent Development
12.8 Immune Pharmaceuticals
12.8.1 Immune Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.8.5 Immune Pharmaceuticals Recent Development
12.9 Tanabe Pharma
12.9.1 Tanabe Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immune-Mediated Inflammatory Diseases Treatment Introduction
12.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
12.9.5 Tanabe Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Immune-Mediated Inflammatory Diseases Treatment Key Market Segments
Table Key Players Immune-Mediated Inflammatory Diseases Treatment Covered
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type 2014-2025
Figure Targeted biologic therapies Figures
Table Key Players of Targeted biologic therapies
Figure Novel therapies Figures
Table Key Players of Novel therapies
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Pharmacy Store Case Studies
Figure Online Pharmacy Case Studies
Figure Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2025 (Million US$)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions 2014-2019
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions 2014-2019
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Manufacturers (2014-2019)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Manufacturers in 2018
Table Global Immune-Mediated Inflammatory Diseases Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immune-Mediated Inflammatory Diseases Treatment Product/Solution/Service
Table Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Type (2014-2019)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Type (2014-2019)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2014-2019)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Market Share by Application (2014-2019)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application in 2018
Figure United States Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table United States Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Figure Europe Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Figure China Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table China Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-20189) (Million US$)
Table China Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table China Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table China Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Figure Japan Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Figure India Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table India Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table India Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table India Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table India Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Figure Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immune-Mediated Inflammatory Diseases Treatment Market Share (2018-2019)
Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2014-2019)
Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Company Details
Table Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Bristol-Myers Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Roche Company Details
Table Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Roche Recent Development
Table Enlivex Therapeutics Company Details
Table Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Enlivex Therapeutics Recent Development
Table Immune Pharmaceuticals Company Details
Table Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Immune Pharmaceuticals Recent Development
Table Tanabe Pharma Company Details
Table Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)(Million US$)
Figure Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2014-2019)
Table Tanabe Pharma Recent Development
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Regions (2019-2025)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Regions in 2025
Figure United States Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immune-Mediated Inflammatory Diseases Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Product (2019-2025)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Product in 2025
Table Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2025)
Figure Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
免疫性血小板減少症治療の世界市場：市場規模・現状・予測 Immune thrombocytopenia (ITP) is a bleeding disorder caused by thrombocytopenia not associated with a systemic disease. Typically, it is chronic in adults, but it is usually acute and self-limited in children. Spleen size is normal in the absence of another underlying condition.The Immune Thrombocyt…- 孤立性肺疾患治療の世界市場：市場規模・現状・予測 Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists.Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are en…
- 筋骨格疾患治療の世界市場：市場規模・現状・予測 Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back.MSDs can arise from a sudden exertion (e.g., lifting a heavy object)[2], or they can arise from makin…
- 筋骨格疾患治療の世界市場：市場規模・現状・予測 Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back.MSDs can arise from a sudden exertion (e.g., lifting a heavy object)[2], or they can arise from makin…
- 世界の腫瘍治療用遺伝子治療市場：専門的調査 Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…